Paragon restructures company to form Nexeon MedSystems
In addition, the company has completed a Series A equity funding round of $24 million with financing provided by SurModics, Guidant (now Abbott Laboratories and Boston Scientific), and
Anixa Biosciences has secured a patent from the Korean Ministry of Intellectual Property (MOIP) for its breast cancer vaccine technology.
In this placebo-controlled, double-blind, randomized two-way crossover trial (CX717-RD-01), 16 volunteers each received either 1500mg of CX717 or matching placebo that was orally administered two hours before each